97 related articles for article (PubMed ID: 19123793)
1. Meloxicam and meloxicam-beta-cyclodextrin complex in model membranes: effects on the properties and enzymatic lipolysis of phospholipid monolayers in relation to anti-inflammatory activity.
Wiecław K; Korchowiec B; Corvis Y; Korchowiec J; Guermouche H; Rogalska E
Langmuir; 2009 Feb; 25(3):1417-26. PubMed ID: 19123793
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic probing of model lipid membranes: phospholipase A2 activity toward monolayers modified by oxicam NSAIDs.
Czapla K; Korchowiec B; Orlof M; Magnieto JR; Rogalska E
J Phys Chem B; 2011 Jul; 115(29):9290-8. PubMed ID: 21682312
[TBL] [Abstract][Full Text] [Related]
3. Differentiating oxicam nonsteroidal anti-inflammatory drugs in phosphoglyceride monolayers.
Czapla K; Korchowiec B; Rogalska E
Langmuir; 2010 Mar; 26(5):3485-92. PubMed ID: 20030324
[TBL] [Abstract][Full Text] [Related]
4. A Langmuir monolayer study of the action of phospholipase A2 on model phospholipid and mixed phospholipid-GM1 ganglioside membranes.
Schulte W; Orlof M; Brand I; Korchowiec B; Rogalska E
Colloids Surf B Biointerfaces; 2014 Apr; 116():389-95. PubMed ID: 24524938
[TBL] [Abstract][Full Text] [Related]
5. Interfacial approach to polyaromatic hydrocarbon toxicity: phosphoglyceride and cholesterol monolayer response to phenantrene, anthracene, pyrene, chrysene, and benzo[a]pyrene.
Korchowiec B; Corvis Y; Viitala T; Feidt C; Guiavarch Y; Corbier C; Rogalska E
J Phys Chem B; 2008 Oct; 112(43):13518-31. PubMed ID: 18834169
[TBL] [Abstract][Full Text] [Related]
6. Interactions of a fungistatic antibiotic, griseofulvin, with phospholipid monolayers used as models of biological membranes.
Corvis Y; Barzyk W; Brezesinski G; Mrabet N; Badis M; Hecht S; Rogalska E
Langmuir; 2006 Aug; 22(18):7701-11. PubMed ID: 16922553
[TBL] [Abstract][Full Text] [Related]
7. Effects of gemini amphiphilic pseudopeptides on model lipid membranes: a Langmuir monolayer study.
Rubio-Magnieto J; Luis SV; Orlof M; Korchowiec B; Sautrey G; Rogalska E
Colloids Surf B Biointerfaces; 2013 Feb; 102():659-66. PubMed ID: 23107944
[TBL] [Abstract][Full Text] [Related]
8. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
Shende PK; Gaud RS; Bakal R; Patil D
Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
[TBL] [Abstract][Full Text] [Related]
9. Elastic liposomes bearing meloxicam-beta-cyclodextrin for transdermal delivery.
Jain SK; Gupta Y; Jain A; Amin S
Curr Drug Deliv; 2008 Jul; 5(3):207-14. PubMed ID: 18673264
[TBL] [Abstract][Full Text] [Related]
10. Density functional calculations on meloxicam-beta-cyclodextrin inclusion complexes.
Snor W; Liedl E; Weiss-Greiler P; Viernstein H; Wolschann P
Int J Pharm; 2009 Nov; 381(2):146-52. PubMed ID: 19446616
[TBL] [Abstract][Full Text] [Related]
11. Tablet formulation containing meloxicam and beta-cyclodextrin: mechanical characterization and bioavailability evaluation.
Ghorab MM; Abdel-Salam HM; El-Sayad MA; Mekhel MM
AAPS PharmSciTech; 2004 Jul; 5(4):e59. PubMed ID: 15760056
[TBL] [Abstract][Full Text] [Related]
12. Interaction of a β-lactam calixarene derivative with a model eukaryotic membrane affects the activity of PLA2.
Korchowiec B; Gorczyca M; Ben Salem A; Regnouf de Vains JB; Rogalska E
Colloids Surf B Biointerfaces; 2013 Mar; 103():217-22. PubMed ID: 23201740
[TBL] [Abstract][Full Text] [Related]
13. Molecular interaction of Rifabutin on model lung surfactant monolayers.
Pinheiro M; Lúcio M; Reis S; Lima JL; Caio JM; Moiteiro C; Martín-Romero MT; Camacho L; Giner-Casares JJ
J Phys Chem B; 2012 Sep; 116(38):11635-45. PubMed ID: 22931247
[TBL] [Abstract][Full Text] [Related]
14. Membrane activity of tetra-p-guanidinoethylcalix[4]arene as a possible reason for its antibacterial properties.
Sautrey G; Orlof M; Korchowiec B; de Vains JB; Rogalska E
J Phys Chem B; 2011 Dec; 115(50):15002-12. PubMed ID: 22081973
[TBL] [Abstract][Full Text] [Related]
15. In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam.
Obach RS; Kalgutkar AS; Ryder TF; Walker GS
Chem Res Toxicol; 2008 Sep; 21(9):1890-9. PubMed ID: 18707140
[TBL] [Abstract][Full Text] [Related]
16. Interaction of nitrofurantoin with lipid langmuir monolayers as cellular membrane models distinguished with tensiometry and infrared spectroscopy.
Machado AC; Caseli L
Colloids Surf B Biointerfaces; 2020 Apr; 188():110794. PubMed ID: 31972441
[TBL] [Abstract][Full Text] [Related]
17. X-ray grazing incidence diffraction and Langmuir monolayer studies of the interaction of beta-cyclodextrin with model lipid membranes.
Flasiński M; Broniatowski M; Majewski J; Dynarowicz-Łatka P
J Colloid Interface Sci; 2010 Aug; 348(2):511-21. PubMed ID: 20493495
[TBL] [Abstract][Full Text] [Related]
18. A two-photon view of an enzyme at work: Crotalus atrox venom PLA2 interaction with single-lipid and mixed-lipid giant unilamellar vesicles.
Sanchez SA; Bagatolli LA; Gratton E; Hazlett TL
Biophys J; 2002 Apr; 82(4):2232-43. PubMed ID: 11916878
[TBL] [Abstract][Full Text] [Related]
19. Structure and properties of phospholipid-peptide monolayers containing monomeric SP-B(1-25) I. Phases and morphology by epifluorescence microscopy.
Biswas N; Shanmukh S; Waring AJ; Walther F; Wang Z; Chang Y; Notter RH; Dluhy RA
Biophys Chem; 2005 Mar; 113(3):223-32. PubMed ID: 15620507
[TBL] [Abstract][Full Text] [Related]
20. Organization of beta-cyclodextrin under pure cholesterol, DMPC, or DMPG and mixed cholesterol/phospholipid monolayers.
Mascetti J; Castano S; Cavagnat D; Desbat B
Langmuir; 2008 Sep; 24(17):9616-22. PubMed ID: 18672913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
